Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Trajectory of cognitive functions in bipolar disorder: for better or worse?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Incidence of suicidal behaviour and violent crime following antidepressant medication: a Danish cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Response to comment on Osler et al: misinterpretation of pre- and post differences invalidate the authors' conclusion

    Research output: Contribution to journalComment/debateResearchpeer-review

  4. Societal costs of Borderline Personality Disorders: a matched-controlled nationwide study of patients and spouses

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Meta-analysis of antidepressant effects of anti-inflammatory drugs-reply

    Research output: Contribution to journalComment/debateResearchpeer-review

View graph of relations

OBJECTIVE: Using national Danish registers, we estimated rates of clozapine-associated cardiac adverse events. Rates of undiagnosed myocarditis were estimated by exploring causes of death after clozapine initiation.

METHOD: Through nationwide health registers, we identified all out-patients initiating antipsychotic treatment (January 1, 1996-January 1, 2015). Rates of clozapine-associated myocarditis and pericarditis within 2 months from clozapine initiation and rates of cardiomyopathy within 1-2 years from clozapine initiation were compared to rates for other antipsychotics. Mortality within 2 months from clozapine initiation was extracted.

RESULTS: Three thousand two hundred and sixty-two patients of a total 7932 patients initiated clozapine as out-patients (41.12%). One patient (0.03%) developed myocarditis, and no patients developed pericarditis within 2 months from clozapine initiation. Two (0.06%) and four patients (0.12%) developed cardiomyopathy within 1 and 2 years respectively. Rates were similar for other antipsychotics. Twenty-six patients died within 2 months from clozapine initiation. Pneumonia (23.08%) and stroke (11.54%) were the main causes of death. We estimated the maximum rate of clozapine-associated fatal myocarditis to 0.28%.

CONCLUSION: Cardiac adverse effects in Danish out-patients initiating clozapine treatment are extremely rare and these rates appear to be comparable to those observed for other antipsychotic drugs.

Original languageEnglish
JournalActa Psychiatrica Scandinavica
Volume137
Issue number1
Pages (from-to)47-53
Number of pages7
ISSN0001-690X
DOIs
Publication statusPublished - Jan 2018

    Research areas

  • Journal Article

ID: 52823626